It has been a difficult time for many this last year or so, and for some of the more unfortunate, it’s getting a lot worse.
A lot of pressure around for a lot of people in some places, and things appear better for others.
Who knows why some appear to see the negative, whereas others like to look forward positively.
I don’t want to be continually reminded of the things that haven’t been great in the past, we REALLY don’t need to be reminded. I would prefer to look forward to the good that will come from this “Major game changer”.
It started remarkably, and now things could be heating up?
As Peeteepoo and ThriftyClown have alluded to above, I am particularly interested to hear what people think of the quarterly statements that:
“As data emerges, we plan to contact a wider group of leading global pharmaceutical companies to discuss veterinary collaborations and engage in discussions with them on identifying the optimal cancers to target commercially. Animal healthcare companies in the US and Germany have shown initial interest and approached PharmAust for discussions.PharmAust has engaged the services of Dr Kim Agnew (Hon BSc, BVSc, MACVSc) to assist with this process. Dr Agnew has 25 years of experience in the animal health industry with business development, product development, regulatory affairs, clinical research, technical support and pharmacovigilance.
Dr. Agnew worked for 20 years at Elanco Animal Health in a variety of management roles including Research and Regulatory Manager, Innovation Manager and Associate Director of Research and Development. Following this, he worked for 5 years at Merial, now Boehringer Ingelheim, as the Research and Development Leader.
Dr. Agnew has been involved in the ground-up development and commercialization of 15 new products, numerous line extensions to existing products, and is named in 6 product development patents.
Furthermore, Dr. Agnew has developed a broad network across various Universities in Australia and has been instrumental in gaining industry support for multiple Australian Research Council (ARC) Linkage Grant collaborations and research projects leveraging the very high quality of science research available in Australia and New Zealand.”
Like shares, as NZT says, “Game changing” drugs are all about getting the message out there and creating a demand.
Is this the first real “money spent” by PAA to protect our position in this way (there were patents applications, etc)? If so makes me think that the expectation of demand might be more imminent than we know?
As I have said before, they (management) generally run off the “smell of an oily rag”, so could we think that the data emerging might be looking as good as we hoped?
There has been occasions in the past where data was about to emerge, but we didn’t put on a “negotiator”.
Good luck to all.
Havenots
Not long now....
Expand
(20min delay)